Abstract Correlation between antibody response and clinical outcome in Staphylococcus aureus bacteremia has yielded conflicting results. Immunization schedules have failed in clinical trials. Is the humoral response toward S. aureus of protective nature? A prospective study was performed in patients with invasive S. aureus (ISA) infections during the period [2003][2004][2005]. The antibody levels were determined at the beginning and at the end of treatment and one month later (n=96, n=71, and n=51, respectively). As controls, 115 healthy individuals were used. A quantitative enzyme-linked immunosorbent assay (ELISA) against eight purified antigens was performed. Bacterial isolates were grouped as to the production of alpha-toxin, agr type, and pulsed-field gel electrophoresis (PFGE) type. Large variations were seen in the antibody levels. The levels in the second sample were the highest. A correlation between agr group, PFGE group, alpha-toxin production, and initial antibody levels was observed. Patients with fatal outcome displayed lower initial antibody levels to all antigens and significantly so in regard to teichoic acid, lipase, enterotoxin A, and scalded skin syndrome toxin. In episodes with complicated bacteremia, initial significantly low levels to teichoic acid and lipase were registered. Low initial antibody levels against several antigens were associated with increased mortality and complicated bacteremia in invasive S. aureus infections. Bacterial properties, strain, and toxin production affected the antibody response.
Introduction
Staphylococcus aureus continues to cause medical problems in the community and healthcare settings. The emergence of multidrug-resistant strains [1] [2] [3] has heightened the need for non-antimicrobial approaches.
A microbiological enigma is the immunologic response in humans towards this bacterium, since most individuals are exposed to S. aureus and can be classified as carriers, intermittent carriers, or non-carriers of the bacteria. High levels of exposure to this organism (among humans) is supported by the observation of human populations describing serum antibodies to most antigens tested for, while rises in serum antibody levels during invasive infections vary greatly [4] . Data from experimental animal studies [5, 6] indicated that this mainly polyclonal B-cell response with antibodies of low affinity is not protective. The vast majority, 60 to 85%, of antibodies in healthy individuals are induced by lipoteichoic acid, which fails to promote opsonization [7, 8] . An individual who has suffered from an S. aureus infection is usually not protected from a subsequent infection and, to date in clinical trials, the development of protective active immunization schedules has failed [9, 10] .
S. aureus pathogenicity is multifactorial and is related to the array of virulence factors among different S. aureus isolates and the inability of humans to develop protective immunity against this pathogen.
The use of S. aureus serology is of limited clinical value for diagnostic purposes. There is no evidence that any serological assay or combination of assays can distinguish between complicated and uncomplicated S. aureus bacteremia [11] . However, there is a mounting interest in the human humoral response to S. aureus in the context of developing future passive and active vaccine strategies [10, 12] . The development of these formulations has been hampered by a lack of knowledge regarding the nature of the specific, protective antibodies in humans during infection, especially in large clinical surveys.
The objective of this study was to describe the humoral immune response to S. aureus in a well-characterized patient cohort with invasive S. aureus (ISA) infections.
Materials and methods

Study population
A prospective study was performed in consecutive patients with ISA infections over a 2-year period between 2003-2005, in western Sweden using healthy individuals as controls [13, 14] . The antibody response in patients was determined by taking three samples: one at the time of diagnosis (n=96), one following the completion of antibiotic treatment (n=71), and the last sample collected during convalescence, i.e., one month after the end of treatment (n=51). From 115 healthy individuals, one serum sample was obtained.
Consent was obtained from the patients or their relatives after written and oral information.
Definitions
Severe sepsis and complicated bacteremia are described in [14] .
For this study, all patients presenting with either hypotension, hypoperfusion, or organ dysfunction were diagnosed with severe sepsis. Complicated bacteremia was defined as bacteremia presented with a secondary focus, such as endocarditis, spondylitis, osteomyelitis, arthritis, as a deep-seated abscess, or pneumonia. Line-associated infections, urinary tract infection, nor soft-tissue infection with no metastatic seeding or bacteremia without focus were not defined as complicated bacteremia.
Antigens
Ribitol teichoic acid (TA) and alpha-toxin (AT) were purchased from PhPlate AB (Stockholm, Sweden). Enterotoxin A (SEA), toxic shock syndrome toxin 1 (TST), and scalded skin syndrome (SSS) toxin were purchased from Toxin Technology (Sarasota, FL, USA). Lipase was kindly supplied by S. Tyski (Medical University of Warzaw, Poland), clumping factor A (ClfA) and extracellular fibrinogen binding (Efb) protein by J.I. Flock (Karolinska Institute, Stockholm).
ELISA
The enzyme-linked immunosorbent assay (ELISA) to determine serum IgG antibodies has been described earlier [15] . The antigen coating concentration was 1 μg/ml for TA, 3.5 μg/ml for AT, 2 µg/ml for ClfA, 0.6 µg/ml for Efb, and 1 μg/ml for TST, SEA, and SSS. Serum samples were diluted two-fold in PBS-T (1/250 to 1/2,000) in AT, ClfA, Efb, TST, and SSS assays, and 1/2,500 to 1/20,000 in TA and lipase assays. The reference serum consisted of pooled sera from six patients with confirmed sepsis [15] . The four dilutions, controls, and reference serum were applied and incubated for 1 h at 37°C. Thereafter, alkaline phosphatase conjugated to goat anti-human antibodies (γ-chain) (Sigma Chemical Co., St. Louis, MO, USA) diluted 1/3,000 in PBS-T was added, and incubation was continued for 2 h at 37°C. Finally, the enzymatic reaction was measured at 405 nm in a TiterTek Multiscan microplate reader (Flow Laboratories, Irvine, Scotland) after approximately 20 min incubation.
Interpretation of ELISA results
The absorbance values were transformed into arbitrary units by using the reference line units calculation method [16] . The dilution curve of each sample was drawn up in parallel to that of the reference serum, after which the two curves were compared. The reference serum was given the value of 1,000 (arbitrary) units for all antigens and the patient serum antibody levels were expressed in these units. Thus, the unit levels obtained for each antigen cannot be directly compared others, since the absolute values are contingent on those of the reference serum.
The upper limits for "normal antibody levels" were established as the upper 95th percentiles of the levels in the healthy individuals. Levels above this cut-off point were designated as high levels (H). A significant increase in antibodies was defined as a 50% increase between two samples (I) and a significant decrease of antibodies was defined as a 50% decrease (D). Positive serology (PS) was considered to exist when a high level was noted in at least one serum sample from a patient with at least two samples and/or a significant increase/decrease of the antibody levels. Some sera were designated as low levels (L). The limits for these levels varied from 50 to 150 for the different antigens as determined in terms of the reproducibility of each respective test. The actual limit values for high and low levels are plotted in Fig. 1 .
Typing of isolated S. aureus strains agr group typing was performed as previously described [14] .
Genome typing by pulsed-field gel electrophoresis (PFGE) was performed in principle as described by Tenover et al. [17] . Visual interpretation of the banding pattern according to cited criteria were made, resulting in a cut-off level of 75% in the dendrograms generated, above which strains were considered to be closely related.
Production of alpha-hemolysin
Screening for alpha-hemolysin production was carried out on nutrient agar plates (8 mm high) containing rabbit erythrocytes. The diameter of the bacterial colonies on the
Clumping factor
Toxic shock syndrom toxin agar plates after incubation at 37°C overnight was <3 mm and the diameter of the zone of hemolysis (mm) was determined.
Statistics
Data were analyzed with SPSS (version 15.0) and Excel 97. Antibody levels were presented as arithmetic/geometric means, and comparisons between groups regarding quantitative variables were analyzed using the Mann-Whitney non-parametric U-test. Category variables were analyzed using the Chi-square test.
Results
The median age was 68 years (mean 64 years) in the patient group as compared to 70 years (mean 61 years) among the controls. Fifty-six percent of the infected patients were men, while the corresponding figure for the healthy individuals was 59%.
Antibody levels in all patients
The antibody levels of all patients were distributed as depicted in Fig. 1 for the various antigens. It is evident that antibody levels against teichoic acid, alpha-toxin, and lipase were higher than those of healthy individuals of corresponding ages. Great interindividual variation in antibody levels was seen, ranging from 50 to 5,000 units against the same antigen in the same sample category. As expected, the levels achieved in the second sample (T2), at the end of treatment, were generally the highest, while the median levels varied relatively little between the three sample occasions. Exceptions to this were lipase and alpha-toxin. High levels (H) were, concordantly, most common for teichoic acid, alpha-toxin, and lipase, where 25 to 42% of the samples were positive in the second sample (Fig. 2a) . In the third sample, drawn at least one month after finishing treatment, the levels against alpha-toxin and lipase remained high.
The kinetics of the antibody levels are shown in Fig. 2b , which shows the frequencies at which the patients appeared to react to the different antigens. With the exception of SSS, 40 to 95% of the patients reacted to a staphylococcal antigen, where lipase stimulated the highest number of patients, regardless of the kinetic parameter measured. Sixty percent of the patients showed an increase in antibody levels against this antigen, and almost 40% showed a decrease. This latter value was probably related to the high levels of antibodies in the first two samples (Figs. 1 and 2 ).
Bacterial properties
Bacterial strains belonging to agr groups I and II produce significantly larger zones of hemolysis as compared with strains belonging to agr group III (Table 1) , indicating a correlation between agr group and the production of alphatoxin. The zones of hemolysis were significantly correlated with the levels of antibodies against alpha-toxin at presentation (Table 1) . We also found a significant correlation between agr group III and a low initial antialpha-toxin antibody level (p<0.001), as determined by the Chi-square analysis (Table 2) .
Screening for tst among the strains revealed that 17% of the strains were positive for the tst gene, with 90% of the tst-positive isolates belonging to agr group III (p< 0.001). A correlation between tst among the strains and absolute anti-TST antibody levels (sample 1 p=0.002 and sample 2 p<0.001) was found among the patients. As seen in Table 2 , agr group III correlates to higher TST antibody levels.
A significant correlation between agr groups and PFGE groups was found, in agreement with earlier studies. Interestingly, we also found that PFGE group 1, which was correlated with small zones of hemolysis (Table 1) , was correlated with low levels of anti-alpha-toxin (Table 2) . PFGE group 1 was also correlated with the presence of tst (p<0.001) among the strains, and strains belonging to PFGE group 1 correlated significantly with high levels of anti-TST antibody among the patients (Table 2) . Surprisingly, the levels of antibodies to teichoic acid, a cell wall constituent expressed in all strains, was significantly correlated to agr group. Strains belonging to agr group 1 showed a positive serology response in 45% of the patients, as compared with 78% of strains belonging to agr group 3 ( Table 2 ). This pattern was even more pronounced in the PFGE groups, as seen in Table 2 .
We did not screen for the gene for scalded skin syndrome toxin, SSS. However, in accordance with the antibody response against the other superantigen TST, differences were found between the various agr groups and PFGE groups. PFGE group 2 and agr group 1 were correlated with initial low levels of antibodies, as compared with agr group 2, which correlated with higher initial antibody levels ( Table 2) .
Clinical outcome
Patients with a fatal outcome only displayed significantly lower initial antibody levels to four antigens ( Table 3 ). The same trend was noted for five antigens in patients with complicated bacteremia, but not for TST, SEA, and SSS. The mean age was significantly higher in the patients with a fatal outcome (79 vs. 63 years, p=0.014). Patients with severe sepsis were also significantly older (75 vs. 60 years, p<0.001), but no difference in the mean age was registered in patients with complicated bacteremia (65 vs. 64 years). We did not detect any significant differences in the time from the start of symptoms to inclusion in the study, or to the first blood sample, in any group, although patients with a fatal outcome tended to have shorter duration of symptoms.
The antibody levels in samples 2 and 3 did not differ significantly between patients with different clinical outcome, such as in patients with bacteremia (n = 84), complicated bacteremia (n=32), severe sepsis (n=28), or in patients suffering from a sequelae (n=37).
No major differences in the antibody production related to the tissue involved were noted. However, patients with endovascular infections (n=7) tended to have initial lower antibody levels towards all antigens. Patients with bacteremia without focus (n=19) tended to have higher antibody levels towards several antigens. Patients with osteomyelitis (n=13) showed a significantly high proportion of increasing levels of ClfA, and a significantly higher frequency of positive serology, than patients without osteomyelitis. Patients with a previous history of ISA infection (n=14) had a trend toward lower risk of both a fatal outcome and complicated bacteremia. They were also significantly less prone to developing severe sepsis, and their initial antibody response to alpha-toxin tended to be higher (83% had high antibody level at presentation as compared to 31% in patients with no previous history of ISA infection). No endovascular infections were registered in patients with a previous history of ISA infection. Figure 3 shows the antibody levels in patients with collagenosis (n=14), a group at risk of developing ISA infection [6] . Low antibody levels as compared with patients without collagenosis were noted. Patients with collagenosis were not significantly older (69 vs. 66 years), had the same duration of symptoms (4 days patients with diabetes mellitus (n=27) and patients with kidney disease (n=13), showed no major differences in antibody levels. Patients with liver disease (n=13) showed (as opposed to collagenosis patients) significantly higher antibody levels against several antigens. Older people (>65 years) displayed a significantly lower proportion of positive serology against the superantigens TST, SEA, and SSS (Table 4 ). The mean antibody levels in older patients were also lower than in younger patients against all of the antigens except Efb in the first sample, while they were significantly lower (Mann-Whitney U-test) only against SSS at the end of antibiotic therapy and one month later (data not shown).
We did not discern any major differences in the antibody response of men and women.
The duration of symptoms correlated positively only to the antibody level to lipase in sample 2, but correlated negatively to lipase in sample 1. We noted a positive correlation between the duration of hospitalization and the antibody levels to ClfA in samples 1 and 3, as well as the antibody levels for alpha-toxin in the same samples. The length of antibiotic treatment was positively correlated with the antibody levels against Efb in samples 1 and 3, and to the antibody levels against ClfA in samples 1, 2, and 3. Discussion This is one of few studies comparing the humoral immune response in a cohort of well-characterized patients with ISA infection with healthy individuals. Dryla et al. [7] reported a pronounced heterogeneity in antibody levels against 19 S. aureus antigens among both healthy individuals and patients with an S. aureus infection. However, the patient group was not uniform, consisting of 17 patients with wound infection, 15 subjects with bacteremia and sepsis, and ten patients with miscellaneous infections.
Our cohort was more homogenous, consisting of only invasive infections, and great variations in antibody levels were still observed. The timing of when serum samples were examined for anti-S. aureus antibodies was not the reason for this, as there was no major correlations between the time from the start of symptoms to sampling and antibody levels. One obvious explanation is that older people (>65 years) develop a dysregulation of humoral immunity responses that can affect the quality and quantity of the antibody response. They displayed lower antibody levels against several antigens, notably towards the superantigens examined in this study (Table 4) . Aging is associated with a shift in antibody isotype from IgG to IgM, and a decline in the activity of lymphocytes [18, 19] Staphylococcal serology is further complicated by the findings of immunomodulating activities in S. aureus, which may be exerted by antigens such as EAP, lipoteichoic acid, and peptidoglycan [20] [21] [22] . In spite of weak antibody response in general, Figs. 1 and 2 show elevated levels of antibodies, as compared with the healthy control group, especially against alpha-toxin and lipase. In fact, as seen in Fig. 2b , about 70% of patients had high (H) antibody levels against lipase in one of the samples and 95% of all patients showed a "positive serology (PS)" against this antigen alone. This finding indicated that patients, in general, do react to S. aureus antigens, although to a varying extent. Analysis of serum IgG with reactivity against teichoic acid and alpha-toxin identified 80% of patients with "positive serology". These contradictory findings may be explained by the fact that, in spite of relatively low absolute levels, the immune system is activated during disease and increases and/or decreases in antibody levels can, therefore, be detected. There was a rise in antibody levels in more than 40% of the patients, even against the TST antigen (Fig. 2b) .
Different groups, displaying variable antibody levels, are at higher risk of ISA infection [13] . Patients with rheumatic disorders develop weak immune responses compared to other risk groups, for example, patients with diabetes mellitus. In order to implement successful strategies such as immunoglobulin therapies or vaccinations, it will be important to know the patient's immune status. We did not demonstrate significantly lower antibody levels among hemodialysis patients. Trials with an anti-capsular vaccine in these patients [9, 10] have been unsuccessful in eliciting a protective immune response. One proposed explanation is their weak immune response.
Invasive infections include infections with variable tissue tropism, for example, endovascular infections, bone infections, and deep soft tissue infections. Surprisingly, we detected only minor differences in antibody levels related to clinical diagnosis. In some cases, it is questionable whether the clinical diagnosis was correct. Only 40% of the patients were examined with ultrasound examination as part of the diagnosis of endocarditis [14] , so we may have underestimated the rate of endocarditis. Still, we do not believe that this is the reason why we did not observe more diagnosis-specific differences. Regardless of which type of invasive infection, a polyclonal B-cells response is generated [5, 6, 23] and may mask a specific, tissue-orientated reaction. However, patients with very high antibody levels were tested for antibody levels against non-related bacterial antigens such as Escherichia coli endotoxin and Streptococcus pneumoniae pneumolysin (data not shown), and there was no sign of a polyclonal increase in antibody levels.
There was a tendency, in some instances significantly, towards a lower antibody response against several antigens in patients with complicated bacteremia as compared to patients with uncomplicated bacteremia (Table 3) . We have shown this previously for alpha-toxin, teichoic acid, and lipase [4] . Others, however, have not made the same observation [24, 25] .
To our knowledge, this is the first time an association has been found between a fatal outcome and initial low antibody response in ISA infection, with the exception of TST [26] [27] [28] . The significance of this observation could be argued, since we cannot conclude whether the observed correlation between low initial antibody levels and a fatal outcome (Table 3) was caused by a lack of specific immune responses or if it resulted from general weak immune responses.
The potential of improved treatment including immunoglobulin therapy has not yet been properly evaluated. A clinical trial with a pooled human immunoglobulin preparation with high antibody titers against ClfA failed, as compared with a placebo, to reduce sepsis and mortality [29] . The patient group consisted of infants; interpretation for other age groups is unclear.
The innate immune response in older patients presenting with concurrent diseases could be a major denominator of clinical outcome. A lack of specific immune response to other antigens than those tested in this study is also possible.
However, we cannot rule out the possibility that, among the examined antibodies, there may be a protective response embedded in the polyclonal reaction. Teichoic acid has been shown to be an essential factor for colonization [30] . In our study, patients with endovascular infections tended to have lower initial antibody levels to all antigens. Ruotsalainen et al. [31] found an elevated initial antistaphylolysin assay (ASTA) titer significantly more often among injection drug users without endocarditis than among individuals with endocarditis (44 vs. 6%). There were no endovascular infections among our patients with recurrent ISA infections, and they displayed higher initial levels of antibodies against alpha-toxin. Vaccination with alpha-toxin in an animal model has been found to protect against S. aureus pneumonia [32] .
Dryla et al. [7] showed that high-titer anti-staphylococcal antibodies remain stable for years in healthy individuals, providing evidence of these antibodies being functional on the basis of opsonophagocytic and neutralizing activity. In a study of pediatric patients infected with communityacquired S. aureus isolates [33] , it has been demonstrated that patients infected with Panton-Valentine leukocidin (PVL)-positive strains developed a dominant IgG anti-PVL antibody response. This response was attributable to a specific humoral response against the antigens Lukf and LukS at the expense of antibody response against other virulence factors. Holtfreter et al. [34] reported that carriers neutralize superantigens with antibodies specific for their colonizing strain, which may explain the observation that carriers who develop sepsis have a better prognosis than noncarriers [35] . Animal studies have also demonstrated that it is possible to elicit a protective response to various bacterial components, including MSCRAMMs (e.g., ClfA, FnBp, and collagen-binding protein) [36] [37] [38] [39] , surface polysaccharides (types 5 and 8) [40] , as well as secreted toxins [41] [42] [43] .
We found an association between both the PFGE group and the agr group and the antibody level to different virulence factors, such as cell wall constituent (teichoic acid), exotoxins (alpha-toxin), and superantigens (TST and SSS) ( Table 2 ). The immune response against alpha-toxin was related both to bacterial factors based on typing groups (agr and PFGE) and to TST based on gene occurrence (tst). A correlation between antibody response to teichoic acid and SSS based on typing groups was also seen in Table 2 .
In conclusion, the antibody response varied among both patients and antigens. Patients with collagenosis showed a lower response and patients with a fatal outcome had lower initial levels of antibodies. A relationship between antibody levels and the nature of the infecting S. aureus strain was seen. Serological analysis of antibody profiles to the respective virulence factors in different patient groups presenting with diseases caused by different S. aureus isolates may help us identify groups of patients who could benefit from adaptive immunotherapeutic interventions.
